About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Journal of Neural Transmission Supplementum
›
top-articles
Journal of Neural Transmission Supplementum
0.5
(top 100%)
impact factor
733
(top 20%)
papers
13.4K
(top 20%)
citations
53
(top 10%)
h
-index
0.5
(top 100%)
impact factor
771
all documents
13.7K
doc citations
83
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Evolution of neuronal changes in the course of Alzheimer’s disease
Journal of Neural Transmission Supplementum
1998
404
2
Parkinson's Disease Society Brain Bank, London: overview and research
Journal of Neural Transmission Supplementum
1993
347
3
Mechanism of 6-hydroxydopamine neurotoxicity
Journal of Neural Transmission Supplementum
1997
308
4
Post mortem studies in Parkinson’s disease — is it possible to detect brain areas for specific symptoms?
Journal of Neural Transmission Supplementum
1999
295
5
Neuropathology of Alzheimer’s disease: a critical update
Journal of Neural Transmission Supplementum
1998
196
6
Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties
Journal of Neural Transmission Supplementum
1994
153
7
Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I]β-CIT and SPECT
Journal of Neural Transmission Supplementum
1997
143
8
Sustained efficacy and safety of idebenone in the treatment of Alzheimer’s disease: update on a 2-year double-blind multicentre study
Journal of Neural Transmission Supplementum
1998
137
9
The calcium ion and cell death
Journal of Neural Transmission Supplementum
1994
126
10
Recent developments in the pathology of Parkinson’s disease
Journal of Neural Transmission Supplementum
2002
122
11
Cytokines in Parkinson's disease
Journal of Neural Transmission Supplementum
2000
122
12
Neuronal vulnerability in Parkinson’s disease
Journal of Neural Transmission Supplementum
1997
118
13
Evolution of Alzheimer’s disease related cortical lesions
Journal of Neural Transmission Supplementum
1998
115
14
Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles
Journal of Neural Transmission Supplementum
1998
112
15
Neurotrophic factors and Alzheimer’s disease: are we focusing on the wrong molecule?
Journal of Neural Transmission Supplementum
2002
108
16
Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders
Journal of Neural Transmission Supplementum
1994
108
17
General aspects of neurodegeneration
Journal of Neural Transmission Supplementum
2003
102
18
Nigral and extranigral pathology in Parkinson's disease
Journal of Neural Transmission Supplementum
1995
98
19
Clinical features of frontal lobe dementia in comparison to Alzheimer’s disease
Journal of Neural Transmission Supplementum
1996
97
20
Free radicals in Alzheimer’s disease
Journal of Neural Transmission Supplementum
1998
96
21
The prognosis of mild cognitive impairment in the elderly
Journal of Neural Transmission Supplementum
1998
90
22
Prevalence of mild cognitive impairment in an elderly community sample
Journal of Neural Transmission Supplementum
1998
88
23
Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey
Journal of Neural Transmission Supplementum
1998
86
24
Animal models of Parkinson’s disease in rodents induced by toxins: an update
Journal of Neural Transmission Supplementum
2003
84
25
The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence
Journal of Neural Transmission Supplementum
1983
81
26
Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides
Journal of Neural Transmission Supplementum
1983
80
27
The N-methyl-D-aspartate antagonist memantine retards progression of Huntington’s disease
Journal of Neural Transmission Supplementum
2004
79
28
On tyramine, food, beverages and the reversible MAO inhibitor moclobemide
Journal of Neural Transmission Supplementum
1988
79
29
Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer’ disease
Journal of Neural Transmission Supplementum
2002
78
30
The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates
Journal of Neural Transmission Supplementum
1998
78
31
The neuropathological diagnosis of Alzheimer disease
Journal of Neural Transmission Supplementum
1998
76
32
Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson’s disease
Journal of Neural Transmission Supplementum
2003
74
33
Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders
Journal of Neural Transmission Supplementum
1998
73
34
Mild cognitive impairment — an early stage of Alzheimer’s disease?
Journal of Neural Transmission Supplementum
1998
73
35
The neuropathology of progressive supranuclear palsy
Journal of Neural Transmission Supplementum
1994
70
36
Positron emission tomography for diagnosis of Alzheimer’s disease and vascular dementia
Journal of Neural Transmission Supplementum
1998
67
37
The MNB/DYRK1A protein kinase: Genetic and biochemical properties
Journal of Neural Transmission Supplementum
2003
67
38
Vascular progressive supranuclear palsy
Journal of Neural Transmission Supplementum
1994
65
39
Mechanisms of cell death in Alzheimer disease — immunopathology
Journal of Neural Transmission Supplementum
1998
65
40
The cytoskeleton in Alzheimer disease
Journal of Neural Transmission Supplementum
1998
65
41
Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes
Journal of Neural Transmission Supplementum
1998
63
42
The MNB/DYRK1A protein kinase: Neurobiological functions and Down syndrome implications
Journal of Neural Transmission Supplementum
2003
63
43
The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome
Journal of Neural Transmission Supplementum
1999
63
44
Morphological substrates of dementia in parkinsonism A critical update
Journal of Neural Transmission Supplementum
1997
61
45
Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in Diffuse Lewy body disease, Pick’s disease, and Corticobasal Degeneration
Journal of Neural Transmission Supplementum
1996
58
46
Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease
Journal of Neural Transmission Supplementum
1995
57
47
Neurotrophic activities and therapeutic experience with a brain derived peptide preparation
Journal of Neural Transmission Supplementum
1998
56
48
Cognitive correlates of cerebral white matter changes
Journal of Neural Transmission Supplementum
1998
55
49
(R)(+)-N-Propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase B
Journal of Neural Transmission Supplementum
1998
55
50
Normal patterns of melatonin levels in the pineal gland and body fluids of humans and experimental animals
Journal of Neural Transmission Supplementum
1986
55
site/software ©
exaly
; All materials licenced under
CC by-SA
.